Publication
Host succinate inhibits influenza virus infection through succinylation and nuclear retention of the viral nucleoprotein »
Antoine Guillon, Deborah Brea-Diakite, Adeline Cezard, Alan Wacquiez, Thomas Baranek, Jérôme Bourgeais, Frédéric Picou, Virginie Vasseur, Léa Meyer, Christophe Chevalier, Adrien Auvet, José M Carballido, Lydie Nadal Desbarats, Florent Dingli, Andrei Turtoi, Audrey Le Gouellec, Florence Fauvelle, Amélie Donchet, Thibaut Crépin, Pieter S Hiemstra, Christophe Paget, Damarys Loew, Olivier Herault, Mustapha Si-Tahar, […] source : https://febs.onlinelibrary.wiley.com/doi/full/10.1111/febs.15229
Human proteinase 3 resistance to inhibition extends to alpha-2 macroglobulin.
N’Guessan K, Grzywa R, Seren S, Gabant G, Juliano MA, Moniatte M, van Dorsselaer A, Bieth JG, Kellenberger C, Gauthier F, Wysocka M, Lesner A, Sienczyk M, Cadene M, Korkmaz B. FEBS J. 2020 Jan 29. source : https://febs.onlinelibrary.wiley.com/doi/full/10.1111/febs.15229
Interleukin- 7 protects against bacterial respiratory infection by promoting IL-17A-producing innate T-cell response.
Hassane M, Jouan Y, Creusat F, Soulard D, Boisseau C, Gonzalez L, Patin EC, Heuzé-Vourc’h N, Sirard JC, Faveeuw C, Trottein F, Si-Tahar M, Baranek T, Paget C. Mucosal Immunol. 2020 Jan;13(1):128-139. Source : Interleukin-7 protects against bacterial respiratory infection by promoting IL-17A-producing innate T-cell response – ScienceDirect
Inhalation of Immuno-Therapeutics/-Prophylactics to Fight Respiratory Tract Infections: An Appropriate Drug at the Right Place!
Inhalation of Immuno-Therapeutics/-Prophylactics to Fight Respiratory Tract Infections: An Appropriate Drug at the Right Sécher T, Mayor A, Heuzé-Vourc’h N. Front Immunol. 2019 Nov 29;10:2760. source : https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2019.02760/full